HeartSciences (HSCS) Shares Outstanding (Diluted Average) (2021 - 2025)
HeartSciences posted quarterly Shares Outstanding (Diluted Average) of $2.8 million for Q4 2025, up 203.07% year-on-year from $917445.0 in Q4 2024, and up 113.3% on a QoQ basis from $1.3 million in Q3 2025.
HeartSciences (HSCS) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $2.8 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 203.07% year-over-year to $2.8 million; the trailing twelve-month figure through Oct 2025 stood at $2.8 million (up 203.07% YoY), and the FY2025 full-year result was $938257.0, up 166.16% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 stood at $2.8 million, up from $1.3 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $7.4 million in Q1 2023 and bottomed at $79506.0 in Q2 2023.
- The 5-year median for Shares Outstanding (Diluted Average) is $1.1 million (2025), against an average of $2.3 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) tumbled 98.42%; it then soared 735.25% in 2024.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $3.3 million in 2021, then soared by 109.27% to $6.9 million in 2022, then sank by 98.42% to $109841.0 in 2023, then jumped by 735.25% to $917445.0 in 2024, then surged by 203.07% to $2.8 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $2.8 million (Q4 2025), $1.3 million (Q3 2025), and $938257.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | HeartSciences | 4.56 Mn | 1.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 2.78 Mn |
| Jul 31, 2025 | 1.30 Mn |
| Apr 30, 2025 | 938,257.00 |
| Jan 31, 2025 | 894,046.00 |
| Oct 31, 2024 | 917,445.00 |
| Jul 31, 2024 | 777,746.00 |
| Apr 30, 2024 | 352,520.00 |
| Jan 31, 2024 | 252,486.00 |
| Oct 31, 2023 | 109,841.00 |
| Jul 31, 2023 | 103,315.00 |
| Apr 30, 2023 | 79,506.00 |
| Jan 31, 2023 | 7.37 Mn |
| Oct 31, 2022 | 6.93 Mn |
| Jul 31, 2022 | 5.65 Mn |
| Apr 30, 2022 | 3.32 Mn |
| Jan 31, 2022 | 3.32 Mn |
| Oct 31, 2021 | 3.31 Mn |
| Jul 31, 2021 | 3.31 Mn |